Breaking News, Promotions & Moves

Resolian Names New CEO

Rob Stachlewitz joins Resolian as CEO, while current CEO Pat Bennett transitions into the role of Chief Business Officer and President of Scientific Affairs.

Author Image

By: Charlie Sternberg

Associate Editor

Resolian, a global bioanalytical and analytical sciences partner supporting drug development and multi-regional clinical trials, has announced leadership changes as the company expands its global footprint and operational capabilities.   Rob Stachlewitz will join Resolian as Chief Executive Officer (CEO), while current CEO Pat Bennett will transition into the newly created role of Chief Business Officer and President of Scientific Affairs. CEO Transition Incoming CEO Rob Stachlewitz joins...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters